04
December 2024
Oasis petitions Kobayashi Pharma to sue executives for $67m
Nikkei Asia
Any examples of strategies, trade ideas, or case studies are intended for illustrative and discussion purposes only, and are not necessarily indicative of the historical or future strategy or performance or the chances of success of any particular strategy. There can be no assurance that investment opportunities described herein will become available in the future. It should not be assumed that any investments described by any models would be profitable if implemented because among other things, assumptions described herein may not materialize. Any specific investments or case studies referenced in this presentation were selected for inclusion herein based on objective, non-performance based criteria solely for the purpose of describing the investment processes and analyses used by Oasis to evaluate such investments. A list of historical investments – including investments that lost money — can be made available upon request. As always, past performance is not necessarily indicative of future results.
04
December 2024
Nikkei Asia
02
December 2024
The Nikkei
28
November 2024
Nikkan Gendai
15
November 2024
The Nikkei
14
November 2024
The Nikkei
14
November 2024
Reuters
14
November 2024
13
November 2024
The Nikkei
07
November 2024
Nikkei Asia
05
November 2024
Kabushiki Shimbun
31
October 2024
Reuters
31
October 2024
Reuters
31
October 2024
Yomiuri Shimbun
30
October 2024
Financial Times
29
October 2024
The Daily Industrial News
21
October 2024
The Nikkei
07
October 2024
The Nikkei
03
October 2024
Bloomberg
25
September 2024
Business Insider Japan
25
September 2024
ITmedia
24
September 2024
The Nikkei
20
September 2024
M&A Online
18
September 2024
The Nikkei
18
September 2024
Nihon Securities Journal
14
September 2024
The Nikkei
11
September 2024
Bloomberg
10
September 2024
The Nikkei
09
September 2024
Kabushiki Shimbun
09
September 2024
The Nikkei
07
September 2024
The Nikkei